MedTrace Logo

The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

NCT01200550 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1233

Last updated 2012-04-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain local epidemiological data for Bosnia and Herzegovina regarding GERD treatment in primary care.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Principal Investigators

  • Srdjan Gornjakovic, MD, PhD · Clinical Center University of Sarajevo; Department of Gastrenterology and HepatologySarajevo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-09-30
Completion
2011-11-30

Countries

  • Bosnia and Herzegovina

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01200550 on ClinicalTrials.gov